Docket
37162
Teva Canada Limited v. Pfizer Canada Inc.
(Federal) (Civil) (By Leave)
(Publication ban in case) (Sealing order)
Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.
| Date | Proceeding | Filed By (if applicable) |
|---|---|---|
| 2017-01-30 | Close file on Leave | |
| 2017-01-20 | Copy of formal judgment sent to Registrar of the Court of Appeal and all parties | |
| 2017-01-20 | Judgment on leave sent to the parties | |
| 2017-01-19 | Judgment of the Court on the application for leave to appeal, The motion for an extension of time to serve and file the application for leave to appeal is granted. The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-422-14, 2016 FCA 161, dated May 31, 2016, is dismissed with costs. Dismissed, with costs |
|
| 2017-01-19 | Decision on motion to extend time to file and /or serve the leave application, see decision on the application. Granted |
|
| 2016-12-12 | All materials on application for leave submitted to the Judges, for consideration by the Court | |
| 2016-12-12 | Submission of motion to extend time to file and/ or serve the leave application, for consideration by the Court | |
| 2016-10-11 | Applicant's reply to respondent's argument, (Book Form), Completed on: 2016-10-11, (Electronic version filed on 2016-10-18) | Teva Canada Limited |
| 2016-10-06 | Reply to the motion to extend time to file and/ or serve the leave application, (Book Form), Completed on: 2016-10-06, (Electronic version filed on 2016-10-18) | Teva Canada Limited |
| 2016-09-29 | Correspondence received from, (Letter Form), the applicant, re: sealing order | Teva Canada Limited |
| 2016-09-29 | Response to the motion to extend the time to file and / or serve the leave application, (Book Form), Redacted copies rec'd 2016/09/29, Completed on: 2016-09-29, (Electronic version filed on 2016-09-29) | Pfizer Canada Inc. |
| 2016-09-29 | Notice of name, (Letter Form), (Electronic version filed on 2016-09-29) | Pfizer Canada Inc. |
| 2016-09-29 | Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-09-29) | Pfizer Canada Inc. |
| 2016-09-29 | Book of authorities, (Book Form), (Electronic version filed on 2016-09-29) | Pfizer Canada Inc. |
| 2016-09-29 | Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2016-09-29, (Electronic version filed on 2016-09-29) | Pfizer Canada Inc. |
| 2016-09-07 | Correspondence received from, (Letter Form), Inquiry regarding the motion to extend time filed by the application, (Printed version filed on 2016-09-07) | Pfizer Canada Inc. |
| 2016-09-01 | Motion to extend the time to file and or serve the application for leave to appeal, (Book Form), Completed on: 2016-09-01, (Electronic version filed on 2016-09-01) | Teva Canada Limited |
| 2016-08-31 | Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 2016/08/31 | |
| 2016-08-30 | Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-08-30) | Teva Canada Limited |
| 2016-08-30 | Notice of name, (Letter Form), (Electronic version filed on 2016-08-30) | Teva Canada Limited |
| 2016-08-30 | Application for leave to appeal, (Book Form), Completed on: 2016-08-30, (Electronic version filed on 2016-08-30) | Teva Canada Limited |
- Date modified: